alexa Long-Term Results of Extracorporeal Shock Wave Lithotripsy in Renal Stone Treatment
Surgery

Surgery

Medical & Surgical Urology

Author(s): Zanetti G, Montanari E, Mandressi A

Abstract Share this page

Extracorporeal shock wave lithotripsy (SWL) treatment for renal stones has been proved safe and effective in the last 10 years. However, we needed to observe the patients for a longer period than a 3-month control to settle the fate of residual fragments. Two hundred fifty-four patients treated with SWL for different types of stones in solitary kidneys have been examined between 24 and 56 months (mean 42 months) after the treatment. When discharged, 31.5% (80) of the patients were stone free, whereas 65.3% (166) had stone dust or passable fragments. After 3 months, 162 (64.8%) of 250 were stone free, and 84 (33.6%) had dust or passable fragments. Twenty-nine (74.4%) of the infected patients had residual fragments, which regrew after discharge in 19 patients (65%). There were 136 stone-free patients (55%) after a followup longer than 24 months (mean 42 months). Recurrence of stones was observed in 34 patients (13.8%), and regrowth of fragments was observed in 55 patients (22.3%). Of 85 evaluable patients with dust and fragments at 3-month followup, 55 (64.7%) had fragment regrowth, 22 (25.8%) were unchanged, and 8 patients (9.4%) were stone free at long-term followup. The fragments still present after 3 months are unlikely to be cleared in a longer followup. The observed incidence of new-onset hypertension in this series was 6.1% (15 patients). In conclusion, SWL should be considered the safe first-choice treatment for all renal stones, in some cases together with auxilliary tools such percutaneous methods.

This article was published in Journal of Endourology and referenced in Medical & Surgical Urology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version